Legal Representation
Attorney
J. Derek Mason
USPTO Deadlines
Next Deadline
107 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 29, 2025
Extension Available
Until October 29, 2025
Application History
30 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 25, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 25, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Apr 24, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Apr 24, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 29, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Sep 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Sep 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Aug 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jul 31, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jul 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 24, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
Jul 24, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 16, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
May 16, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
May 16, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
May 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Apr 30, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Apr 30, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 30, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
Jan 30, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
Oct 31, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Oct 31, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Oct 31, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Oct 30, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Oct 30, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Oct 30, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Oct 26, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 20, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Sep 19, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 25, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical additives for altering color in cosmetic preparations; substances in the nature of chemicals for use in solar cells and photovoltaic cells
Class 002
Particulate energy converting additives for altering color in paint, pigment and colorant preparations; paint preparations in the nature of paints containing particulate energy converting additives for altering color; pigment preparations in the nature of pigments containing particulate energy converting additives for altering color; colorant preparations in the nature of colorants containing particulate energy converting additives for altering color
Class 003
Additives for altering color in cosmetic preparations, namely, coloring preparations and non-medicated skin care preparations; cosmetic preparations
Class 005
Pharmaceutical preparations for biological tissue regeneration; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of brain disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune disease and disorders; pharmaceutical agents for treating a disease, condition, or disorder of the tissues of a subject by detecting and triggering biophotons; pharmaceutical agents for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intercellular communication; pharmaceutical agents for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intracellular communication; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering biophotons; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intercellular communication; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intracellular communication; preparations for sanitization and remediation of air supply, water supply, and biological materials for medical purposes
Class 009
Energy storage systems comprised of solar cells, photovoltaic cells and modules and any combination thereof; optical fibers for light or color transmission; optical communication networks comprised of optical fibers
Class 010
Medical device for detection of biophotons; medical device for detection of intercellular communication; medical device for detection of intracellular communication; medical device for treating a disease, condition and disorder by detection of intercellular communication; medical device for treating a disease, condition and disorder by detection of intracellular communication; medical device for triggering of biophotons; medical device for detection of intercellular communication; medical device for triggering of intracellular communication; medical device for treating a disease, condition and disorder by triggering of intercellular communication; medical device for treating a disease, condition and disorder by triggering of intracellular communication
Additional Information
Design Mark
The mark consists of three swirl designs that converge in the center of the image.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
002
003
005
009
010